ASE · Biotechnology

LCTX (LCTX) Stock

$1.13 -0.88% ASE: LCTX Healthcare

Valuation

MetricValue
Price$1.13
Market Cap$281.71M
P/E Ratio-17.61
P/B Ratio7.46
P/S Ratio21.68
EPS (TTM)$-0.08
52-Week High$2.09
52-Week Low$0.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1.05%
ROA-12.06%
ROCE-50.00%
Gross Margin-140.00%
Operating Margin-146.67%
Net Margin-434.44%
Debt/Equity0.04
Current Ratio5.36

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$15.0M$9.0M$9.0M$15.0M
Operating Profit$-49.0M$-23.0M$-25.0M$-21.0M$-22.0M
Net Profit$-43.0M$-26.0M$-21.0M$-19.0M$-64.0M
EPS$-0.26$-0.15$-0.12$-0.09$-0.28
Op Margin-1263.1%-153.2%-276.5%-226.1%-149.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$175.0M$124.0M$101.0M$113.0M$113.0M
Total Liabilities$84.0M$52.0M$39.0M$36.0M$69.0M
Cash$56.0M$11.0M$35.0M$46.0M$41.0M
Borrowings$3.0M$4.0M$3.0M$3.0M$2.0M

Latest News

Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan MarketBeat · Jul 14, 2026 Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease Business Wire · Jul 13, 2026 Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit Business Wire · Jul 6, 2026 Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage Simply Wall St. · Jun 18, 2026 How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets Simply Wall St. · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$1.0M$-29.0M$-23.0M$-19.0M
Investing Cash Flow$9.0M$-47.0M$46.0M$-3.0M$-14.0M
Financing Cash Flow$6.0M$2.0M$0$0$0
Net Cash Flow$23.0M$-44.0M$24.0M$10.0M$-5.0M
Free Cash Flow$-24.0M$1.0M$-29.0M$-24.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-6.96%
Quick Ratio6.89
Interest Coverage—
Return 1Y-0.93%
Return 3Y-23.57%
Return 5Y-54.81%

Ownership

Insiders Held4.93%
Institutions Held47.46%
Institutions Float Held49.92%
Institutional HolderSharesReport Date
Broadwood Capital, Inc.49,560,9922026-03-31
Vanguard Capital Management LLC8,318,6852026-03-31
Defender Capital, LLC6,598,8992026-06-30
Millennium Management Llc5,561,3742026-03-31
Raffles Associates Lp5,362,7882026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADCTADC Therapeutics S.A. $1.19 +3.48% -1.09 $151.36M 0.00%
AUTLAutolus Therapeutics plc $1.46 -13.61% -1.35 — 0.00%
BNTC $13.07 -0.46% -11.78 $449.01M 0.00%
FULC $3.73 +0.13% -5.17 $201.56M 0.00%
GALTGalectin Therapeutics Inc. $3.33 -4.18% -8.53 $218.97M 0.00%

About LCTX

LCTX is led by CEO Brian Culley, employs 70 people, headquartered in US, publicly traded since 1992.

LCTX stock trades at $1.13 with a market capitalization of $281.71M. The stock is valued at a price-to-earnings (P/E) ratio of -17.61, price-to-book of 7.46, price-to-sales of 21.68. Over the past 52 weeks the stock has ranged between $0.85 and $2.09, and currently trades 45.9% below its 52-week high.

On profitability, LCTX generates a return on equity (ROE) of -1.05%, return on capital employed of -50.00%, an operating margin of -146.67%, a net profit margin of -434.44%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides